NewAmsterdam Pharma Company N.V. company logo
NewAmsterdam Pharma Company N.V. logo

NAMS EV/EBITDA

EV/EBITDA

-16.550.19-1.16%

Summary

Current Value
As of today, NAMS EV/EBITDA is -16.55, down -1.16% on
All-time High
NAMS EV/EBITDA is currently -261.35% below its historical high of -4.58 set on
1-Year High
NAMS EV/EBITDA reached a 1-year high of -4.58 on
1-Year Low
NAMS EV/EBITDA reached a 1-year low of -19.71 on
1-Year Change
NAMS EV/EBITDA is down -49.91% year-over-year
Sector rank
NAMS EV/EBITDA is higher than 8.92% of companies in Healthcare sector

Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

NAMS Performance
MetricDateValue1D1M3MYTD1Y3Y5Y
EV/EBITDA-16.55-1.2%-0.2%-11.3%-2.5%-49.9%+91.3%
Price$35.80+1.0%+0.1%+8.9%+2.0%+40.1%+202.3%
PE Ratio-
TTM Revenue$35.24M-44.9%-44.9%+7.5%+100.0%+100.0%
TTM EPS-$2.04-26.6%-26.6%-23.9%-896.1%-10000.0%
Enterprise Value$3.36B+1.2%+0.2%+11.3%+2.5%+74.1%+247.5%
TTM EBITDA-$202.72M-17.9%-17.9%-54.2%-3887.7%-10000.0%
Market Cap$4B+1.0%+0.1%+9.2%+2.0%+47.0%+320.2%

Highs

NAMS EV/EBITDA Highs Comparison
PeriodHighDateCurrent
1M-15.25-8.5%
3M-14.87-11.3%
6M-8.80-88.1%
1Y-4.58-261.4%
3Y-4.58-261.4%
5Y-4.58-261.4%
All-4.58-261.4%

Lows

NAMS EV/EBITDA Lows Comparison
PeriodLowDateCurrent
1M-17.36+4.7%
3M-19.71+16.0%
6M-19.71+16.0%
1Y-19.71+16.0%
3Y-284.06+94.2%
5Y-1,188.71+98.6%
All-1,188.71+98.6%

History

DateValueChange
-16.55-2.5%
-16.15-45.1%
-11.13+93.6%
DateValueChange
-174.80-72.8%
-101.16-

FAQ

  • What is the current EV/EBITDA of NAMS?

    As of today, NAMS EV/EBITDA is -16.55

  • What is NAMS EV/EBITDA 1-year high?

    NAMS EV/EBITDA reached a 1-year high of -4.58 on April 10, 2025

  • What is NAMS EV/EBITDA 1-year low?

    NAMS EV/EBITDA reached a 1-year low of -19.71 on November 26, 2025

  • What is 1-year change in NAMS EV/EBITDA?

    NAMS EV/EBITDA is down -49.91% year-over-year

  • What is 3-year change in NAMS EV/EBITDA?

    NAMS EV/EBITDA is up +91.29% over the past 3 years

  • How far is NAMS EV/EBITDA from its all-time high?

    NAMS EV/EBITDA is currently -261.35% below its historical high of -4.58 set on April 10, 2025

  • How does NAMS EV/EBITDA rank versus sector peers?

    NAMS EV/EBITDA is higher than 8.92% of companies in Healthcare sector

EV/EBITDA Formula

EV/EBITDA =  

Data Sources & References

  1. NAMS Official Website www.newamsterdampharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1936258/000119312525265796/0001193125-25-265796-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1936258/000095017025027339/0000950170-25-027339-index.htm
  4. NAMS Profile on Yahoo Finance finance.yahoo.com/quote/NAMS
  5. NAMS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nams